Compounds > 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose
Page last updated: 2024-08-24

1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and 3,4-dihydroxyphenylpropionic acid

1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose has been researched along with 3,4-dihydroxyphenylpropionic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bazinet, L; Cao, S; Christensen, KA; Clardy, J; Cryan, LM; Habeshian, KA; Rogers, MS1
Al-Asri, J; Fazekas, E; Görick, C; Gyémánt, G; Lehoczki, G; Melzig, MF; Mortier, J; Perdih, A; Wolber, G1

Other Studies

2 other study(ies) available for 1,2,3,4,6-pentakis-O-galloyl-beta-D-glucose and 3,4-dihydroxyphenylpropionic acid

ArticleYear
1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose inhibits angiogenesis via inhibition of capillary morphogenesis gene 2.
    Journal of medicinal chemistry, 2013, Mar-14, Volume: 56, Issue:5

    Topics: Angiogenesis Inhibitors; Animals; Cell Line, Tumor; Cell Proliferation; Endothelial Cells; Humans; Hydrolyzable Tannins; Mice; Neovascularization, Pathologic; Receptors, Peptide

2013
From carbohydrates to drug-like fragments: Rational development of novel α-amylase inhibitors.
    Bioorganic & medicinal chemistry, 2015, Oct-15, Volume: 23, Issue:20

    Topics: alpha-Amylases; Carbohydrates; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Models, Molecular; Molecular Structure; Structure-Activity Relationship

2015